Direct Evidence for Multiple Self-Renewal Divisions of Human In Vivo Repopulating Hematopoietic Cells in Short-Term Culture
Open Access
- 1 October 1999
- journal article
- Published by American Society of Hematology in Blood
- Vol. 94 (7) , 2161-2168
- https://doi.org/10.1182/blood.v94.7.2161.419k32_2161_2168
Abstract
Recently, culture conditions that stimulate the proliferation of primitive hematopoietic cells defined by various phenotypic and functional endpoints in vitro have been identified. However, evidence that they support a high probability of self-renewal leading to a large net expansion in vitro of transplantable cells with lympho-myeloid repopulating ability has been more difficult to obtain. The present study was designed to investigate whether the low overall expansion of human repopulating hematopoietic cells seen in vitro reflects a selective unresponsiveness of these rare cells to the growth factors currently used to stimulate them or, alternatively, whether they do proliferate in vitro but lose engrafting potential. For this, we used a high-resolution procedure for tracking and reisolating cells as a function of their proliferation history based on the loss of cellular fluorescence after staining with (5- and 6-) carboxyfluorescein diacetate succinimidyl ester. The results show that the vast majority of long-term culture-initiating cells and in vivo lympho-myeloid competitive repopulating units present in 5-day suspension cultures initiated with CD34+ human cord blood and fetal liver cells are the progeny of cells that have divided at least once in response to stimulation by interleukin-3, interleukin-6, granulocyte colony-stimulating factor, Steel factor, and Flt3-ligand. Thus, most human repopulating cells from these two sources are stimulated to undergo multiple divisions under currently used short-term suspension culture conditions and a proportion of these retain engraftment potential.Keywords
This publication has 33 references indexed in Scilit:
- Dependence of Human Stem Cell Engraftment and Repopulation of NOD/SCID Mice on CXCR4Science, 1999
- A newly discovered class of human hematopoietic cells with SCID-repopulating activityNature Medicine, 1998
- Retrovirus-Mediated Gene Transfer into Human CD34+38lowPrimitive Cells Capable of Reconstituting Long-Term CulturesIn Vitroand Nonobese Diabetic–Severe Combined Immunodeficiency MiceIn VivoHuman Gene Therapy, 1998
- In Vitro Generation of Lymphohematopoietic Cells from Endothelial Cells Purified from Murine EmbryosImmunity, 1998
- High‐resolution cell division tracking demonstrates the Flt3‐ligand‐dependence of human marrow CD34+CD38− cell production in vitroBritish Journal of Haematology, 1997
- Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapyNature Medicine, 1996
- Long-Term Lymphohematopoietic Reconstitution by a Single CD34-Low/Negative Hematopoietic Stem CellScience, 1996
- Differential Requirements for α4 Integrins during Fetal and Adult HematopoiesisCell, 1996
- Peripheralization of hemopoietic progenitors in primates treated with anti-VLA4 integrin.Proceedings of the National Academy of Sciences, 1993
- Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors.The Journal of Experimental Medicine, 1979